Role of elevated plasma transforming growth factor-β1 levels in wound healing

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 1115-1124

  Shah, Mamta ^a   Revis Jr , Don ^b   Herrick, Sarah ^a   Baillie, Robin ^a   Thorgeirson, Snorri ^b   Ferguson, Mark ^a   Roberts, Anita ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROLINE; POLYVINYL ALCOHOL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCAR FORMATION; SKIN INJURY; WOUND HEALING;

EID: 0032953182     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65364-3     Document Type: Article

References (33)

1. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS: Transforming growth factor type β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171
2. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty JP, Angel P, Heath JK: Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987, 6:1899-1904
3. Roberts AB, Sporn MB: Transforming growth factor-β. The Molecular and Cellular Biology of Wound Repair, ed 2. Edited by Clark RAF. New York, Plenum Press 1996, pp 275-308
4. Shah M, Foreman DM, Ferguson MWJ: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous wounds reduces scarring. J Cell Sci 1995, 108:983-1002
5. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292
6. Broekelmann TJ, Limper AH, Colby TV, McDonald JA: Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991, 88:6642-6646
7. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 1993, 328:1592-1598
8. Terrell TG, Working PK, Chow CP, Green JD: Pathology of recombinant human transforming growth factor β1 in rats and rabbits. Int Rev Exp Pathol 1993, 346:43-67
9. Sanderson N, Factor V, Nagy P, Kopp J, Kondiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson S: Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995, 92:2572-2576
10. Bottinger EP, Factor VM, Tsang ML-S, Weatherbee JA, Kopp JB, Qian SW, Wakefield LM, Roberts AB, Thorgeirsson SS, Sporn MB: The recombinant proregion of transforming growth factor-TGF-β1 (LAP) inhibits active transforming growth factor-β1 in transgenic mice. Proc Natl Acad Sci USA 1996, 93:5877-5882
11. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 1996, 74:991-1003
12. Shah M, Foreman DM, Ferguson MWJ: Neutralising antibodies to TGF-β1,2 reduce cutaneous scarring in adult rodents. J Cell Sci 1994. 107:1137-1157
13. Shah M, Foreman DM, Ferguson MWJ: Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 1992, 339:213-214
14. Junqueira LCU, Bignolas G, Brentani RR: Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979, 11:447-455
15. Flanders KC, Thompson NL, Cissel DS, van Obberghen-Schilling E, Baker CC, Kass ME, Ellingsworth LR, Roberts AB, Sporn MB: Transforming growth factor-β1: histochemical localisation with antibodies to different epitopes. J Cell Biol 1989, 108:653-660
16. Stegmann H, Stalder K: Determination of hydroxyproline. Clin Chim Acta 1967, 18:267-273
17. Glick AB, McCune BK, Abdulkarem N, Flanders KC, Lumadue JA, Smith JM, Sporn MB: Complex regulation of TGF-β expression by retinoic acid in the vitamin A-deficient rat. Development 1991, 111: 1081-1086
18. Beck LS, DeGuzman L, Lee WP, Xu Y, Siegel MW, Amento EP: One systemic administration of transforming growth factor-β1 reverses age-or glucocorticoid-impaired wound healing. J Clin Invest. 1993, 92:2841-2849
19. Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MWJ: Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nature Med 1997, 3:1209-1215
20. Logan A, Berry: Transforming growth factor-β1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 1993, 14: 337-342
21. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V: TGF-β3 stimulates and regulates collagen synthesis through TGF-β1-dependent, and independent mechanisms. J Invest Dermatol 1997 108: 258-262
22. O'Reilly MA, Danielpour D, Roberts AB, Sporn MB: Regulation of expression of transforming growth factor-β2 by transforming growth factor-β isoforms is dependent upon cell type. Growth Factors 1992, 6:193-201
23. Bascom CC, Wolfshohl JR, Coffey R Jr, Madisen L, Webb NR, Purchio AR, Derynck R, Moses HL: Complex regulation of transforming growth factor β1, β2 and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and 2. Mol Cell Biol 1989, 9:5508-5515
24. Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471
25. Nakao A, Afrakhte M, Moren A, NakayamaT, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin N-E, Heldin CH, ten Dijke P: Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 1997, 389:631-635
26. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim K-Y, Sporn MB, Karin M, Roberts AB: Autoinduction of TGF-β1 is mediated by the AP-1 complex. Mol Cell Biol 1990, 10:1492-1497
27. Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1997, 1333:F105-F150
28. Chen RH, Ebner R, Derynck R: Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993, 260:1335-1338
29. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA: Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996, 97:1436-1446
30. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HL Jr: Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions: conversion from an antiproliferative to profibrotic response to TGF-β1. J Clin Invest 1995, 96:2667-2675
31. Broadley KN, Aquino AM, Hicks B, Ditesheim JA, McGee GS, Demetriou AA, Woodward SC, Davidson JM: The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-β and basic fibroblast growth factor. Biotechnol Ther 1989, 1:55-68
32. Sporn MB, Roberts AB, Shull JH, Smith JM, Ward JM, Sodek J: Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 1983, 219:1329-1331
33. Roberts AB: Molecular and cell biology of TGF-β. Miner Electrolyte Metab 1998, 24:111-119